| Combination therapy with anti–CTLA-4 and anti–PD-1 leads to distinct immunologic changes in vivo R Das, R Verma, M Sznol, CS Boddupalli, SN Gettinger, H Kluger, ... The Journal of Immunology 194 (3), 950-959, 2015 | 465 | 2015 |
| Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice R Verma, T Strowig, R Das, S Koduru, A Hafemann, S Hopf, MH Kocoglu, ... Nature medicine 22 (11), 1351-1357, 2016 | 148 | 2016 |
| Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation S Nair, CS Boddupalli, R Verma, J Liu, R Yang, GM Pastores, PK Mistry, ... Blood, The Journal of the American Society of Hematology 125 (8), 1256-1271, 2015 | 135 | 2015 |
| Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells CS Boddupalli, N Bar, K Kadaveru, M Krauthammer, N Pornputtapong, ... JCI insight 1 (21), 2016 | 133 | 2016 |
| Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets K Sehgal, R Das, L Zhang, R Verma, Y Deng, M Kocoglu, J Vasquez, ... Blood, The Journal of the American Society of Hematology 125 (26), 4042-4051, 2015 | 127 | 2015 |
| ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells CS Boddupalli, S Nair, SM Gray, HN Nowyhed, R Verma, JA Gibson, ... The Journal of clinical investigation 126 (10), 3905-3916, 2016 | 104 | 2016 |
| Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial A Naing, DJ Wong, JR Infante, WM Korn, R Aljumaily, KP Papadopoulos, ... The Lancet Oncology 20 (11), 1544-1555, 2019 | 94 | 2019 |
| Significantly reduced regulatory T cell population in patients with untreated multiple myeloma R Gupta, P Ganeshan, M Hakim, R Verma, A Sharma, L Kumar Leukemia research 35 (7), 874-878, 2011 | 68 | 2011 |
| Clinical and serologic responses after a two-dose series of high-dose influenza vaccine in plasma cell disorders: a prospective, single-arm trial AR Branagan, E Duffy, RA Albrecht, DL Cooper, S Seropian, TL Parker, ... Clinical Lymphoma Myeloma and Leukemia 17 (5), 296-304. e2, 2017 | 47 | 2017 |
| Complete response after autologous stem cell transplant in multiple myeloma L Kumar, N Iqbal, A Mookerjee, RK Verma, OD Sharma, A Batra, ... Cancer medicine 3 (4), 939-946, 2014 | 35 | 2014 |
| RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development R Verma, S Su, DJ McCrann, JM Green, K Leu, PR Young, PJ Schatz, ... Journal of Experimental Medicine 211 (9), 1715-1722, 2014 | 30 | 2014 |
| Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins A Dev, SM Byrne, R Verma, PG Ashton-Rickardt, DM Wojchowski Journal of Experimental Medicine 210 (2), 225-232, 2013 | 29 | 2013 |
| Recent advances in the management of multiple myeloma. L Kumar, R Verma, VR Radhakrishnan The national medical journal of india 23 (4), 210-218, 2010 | 26 | 2010 |
| Defining an EPOR-regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO-dependent erythroblast formation S Singh, A Dev, R Verma, A Pradeep, P Sathyanarayana, JM Green, ... PLoS One 7 (7), e38530, 2012 | 24 | 2012 |
| Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias AR Branagan, E Duffy, G Gan, F Li, C Foster, R Verma, L Zhang, ... Blood Advances 5 (5), 1535-1539, 2021 | 19 | 2021 |
| Chemoselective synthesis of n-arylenaminones and 3-aroylquinolines by synergistic control of temperature and amount of catalyst P Zhou, B Hu, K Rao, L Li, J Yang, C Gao, F Wang, F Yu Synlett 29 (04), 519-524, 2018 | 15 | 2018 |
| Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles S Singh, R Verma, A Pradeep, K Leu, RB Mortensen, PR Young, M Oyasu, ... PloS one 7 (1), e29064, 2012 | 14 | 2012 |
| Assessment of natural mycorrhizal colonization and soil fertility status of lemongrass [(Cymbopogon flexuosus, Nees ex Steud) W. Watson] crop in subtropical India U Pankaj, SK Verma, M Semwal, RK Verma Journal of Applied Research on Medicinal and Aromatic Plants 5, 41-46, 2017 | 13 | 2017 |
| Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC) JR Hecht, KP Papadopoulos, GS Falchook, MR Patel, JR Infante, ... Investigational new drugs 39, 182-192, 2021 | 10 | 2021 |
| Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation T Mori, R Verma, R Nakamoto-Matsubara, KT Siu, C Panaroni, KS Fulzele, ... Blood Cancer Journal 11 (12), 194, 2021 | 7 | 2021 |
Richard A. FlavellSterling Professor of Immunobiology, Yale University, HHMI InvestigatorVerified email at yale.edu
